Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Clinical trial NCT01491971 · COMPLETED
Trial details
- NCT number
- NCT01491971
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2012-11-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.